Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Santé Ventures Stories

2013-06-10 20:21:42

AUSTIN, Texas, June 10, 2013 /PRNewswire/ -- TVA Medical, Inc. (TVA Medical), a medical device company developing minimally invasive therapies for End-Stage Renal Disease (ESRD), announced today that it received $9.5 MM in Series B financing. S3 Ventures led the round and was joined by TriStar Technology Ventures and existing investor, Santé Ventures. The funding will be used to further validate the Company's endovascular technology and complete additional clinical studies to...